Teva to Present at the 31st Annual J.P. Morgan Healthcare Conference JPMorgan Healthcare Conference 2013 Business Wire JERUSALEM -- January 7, 2013 Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the J.P. Morgan Healthcare Conference in San Francisco, CA. Dr. Jeremy Levin, President & CEO, Teva Pharmaceutical Industries Ltd., will present on Tuesday, January 8, 2013. What: Teva Presentation at the 31^st Annual J.P. Morgan Healthcare Conference Who: Dr. Jeremy Levin, President and CEO, Teva Pharmaceutical Industries Ltd. When: Tuesday, January 8, 2013 at 10:30 a.m. (PST) Where: http://jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticker=TEVA Live over the Internet – log on to the Web at the address above and register How: for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's largest generic drug maker, with a global product portfolio of more than 850 molecules and a direct presence in about 60 countries. Teva's branded businesses focus on CNS, oncology, pain, respiratory and women's health therapeutic areas as well as biologics. Teva currently employs approximately 46,000 people around the world and reached $18.3 billion in net revenues in 2011. Contact: Teva Pharmaceutical Industries Ltd. IR: United States Kevin C. Mannix, 215-591-8912 Israel Tomer Amitai, 972 (3) 926-7656 or PR: United States Denise Bradley, 215-591-8974 Israel Shir Altay-Hagoel, 972 (3) 926-7590
Teva to Present at the 31st Annual J.P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.